Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPILIMUMAB vs TREMELIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPILIMUMAB vs TREMELIMUMAB: Safety Overview

Metric IPILIMUMAB TREMELIMUMAB
Total FAERS Reports 36,528 2,387
Deaths Reported 8,043 594
Death Rate 22.0% 24.9%
Hospitalizations 17,031 1,510
Average Patient Age 62.9 yrs 64.7 yrs
% Female Patients 35.4% 31.6%
Manufacturer E.R. Squibb & Sons, L.L.C. AstraZeneca Pharmaceuticals LP
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A